US EditionDana-Farber Develops Blood Test for Multiple Myeloma Diagnosis
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.5 Articles
5 Articles
analytica-world.com
bionity.comResearchers at the Dana Colorer Cancer Institute have developed a blood test that could alter the diagnosis and monitoring of multiple myeloma (MM) and its precursor diseases. The new method called SWIFT-seq uses single cell sequencing to create a profile of circulating myeloma.
Researchers at the Dana-Farber Oncology Institute (Boston, USA) have developed a blood test that could transform the diagnosis and follow-up of multiple myeloma (MM) and its precursor diseases.The new method, known as SWIFT-seq, uses single-cell sequencing to profile circulating tumor cells (CTC) in the blood, offering a non-invasive alternative to traditional bone marrow biopsies.Multiple myeloma is complex bone marrow cancer, often preceded by…
Multiple Myeloma Diagnosed and Monitored via New Blood Test
Researchers at the Dana-Farber Cancer Institute in Boston, Massachusetts, have developed a new blood testing method that could change the way multiple myeloma and its preceding conditions are diagnosed and monitored. The technique is based on single-cell sequencing and is a non-invasive method for diagnosing and monitoring multiple myeloma, bypassing the need for painful bone marrow biopsies. Multiple myeloma can be preceded by other conditions…
Dana-Farber develops blood test for multiple myeloma diagnosis
Dana-Farber Cancer Institute has unveiled a new blood test that could change the way multiple myeloma (MM) and its precursor conditions.The post Dana-Farber develops blood test for multiple myeloma diagnosis appeared first on Medical Device Network.
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
